Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196781 · ClinicalTrials.gov registry record · Phase 3
Treatment Decision Making in Early-Stage Prostate Cancer
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT00196781 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 168 participants.
The verdict
NCT00196781, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
We plan to test the effectiveness of a recently developed computer-based program that is designed to improve patient knowledge about prostate cancer treatments. It is also designed to help men clarify their values using a computer-based 'decision aid.' A decision aid gives patients tools to help them understand their own values and how these values may be related to their choice of different forms of therapy for prostate cancer. In order to test the effectiveness of the decision aid, men will be assigned on a chance basis to receive either 1) the computer program that includes the information about prostate cancer treatments alone, or 2) the computer program that contains both the information and the decision aid. We expect that men in decision aid group will be more active in their treatment decision and will have improved knowledge, quality of life, and satisfaction with the treatment decision relative to men who only receive the information.
Interventions
- BEHAVIORAL CD-ROM-based prostate cancer treatment education
- BEHAVIORAL CD-ROM-based prostate ca treatment education+decision tools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2002-09 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196781
The ClinicalTrials.gov registry entry for NCT00196781 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CD-ROM-based prostate cancer treatment education is the first listed.
NCT00196781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196781 about?
NCT00196781 is a clinical study titled "Treatment Decision Making in Early-Stage Prostate Cancer". We plan to test the effectiveness of a recently developed computer-based program that is designed to improve patient knowledge about prostate cancer treatments. It is also designed to help men clarify their values using a computer-based 'decision aid.' A decision aid gives patients tools to help the...
What is the current status of trial NCT00196781?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2002-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00196781?
The interventions under investigation include: CD-ROM-based prostate cancer treatment education (BEHAVIORAL), CD-ROM-based prostate ca treatment education+decision tools (BEHAVIORAL).
Who is sponsoring clinical trial NCT00196781?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.